Mereo BioPharma (MREO) Return on Capital Employed (2024 - 2026)
Mereo BioPharma (MREO) posted quarterly Return on Capital Employed of 101.57% for Q1 2026, down 2654.0% year-on-year from 3.98% in Q1 2025, and down 15.12% on a QoQ basis from 88.23% in Q4 2025.
Mereo BioPharma (MREO) Return on Capital Employed (2024 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Return on Capital Employed for 3 consecutive years, with 101.57% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed fell 2654.0% year-over-year to 101.57% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 101.57% (down 2654.0% YoY) and the FY2025 annual result came in at 70.55%, up 1169.0% from the prior year.
- Return on Capital Employed retreated to 101.57% in Q1 2026 per MREO's latest filing, from 88.23% in the prior quarter.
- Over the last five years, Return on Capital Employed for MREO reached as high as 50.13% in Q3 2024 and fell as low as 101.57% in Q1 2026.
- A 3-year average of 74.66% and a median of 75.03% in 2025 frame the typical range for Return on Capital Employed.
- The largest YoY upside for Return on Capital Employed was 1578 bps in 2025 against a maximum downside of 4006 bps in 2025.
- Year by year, Return on Capital Employed stood at 68.92% in 2024, then fell by 28 bps to 88.23% in 2025, then decreased by 15 bps to 101.57% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 101.57%, 88.23%, and 90.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | -101.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.57% |
| Dec 31, 2025 | -88.23% |
| Sep 30, 2025 | -90.19% |
| Jun 30, 2025 | -80.02% |
| Mar 31, 2025 | -75.03% |
| Dec 31, 2024 | -68.92% |
| Sep 30, 2024 | -50.13% |
| Jun 30, 2024 | -64.24% |
| Mar 31, 2024 | -53.58% |